SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Haleos Labs Limited Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540679 INE320X01016 684.2694293 HALEOSLABS 0.11 420.24 22.07 62.97 10
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales77.8479.0485.43
Other Operating Income0.000.000.00
Other Income 0.441.012.20
Total Income78.2880.0587.63
Total Expenditure 67.0468.2179.83
PBIDT11.2411.857.80
Interest 1.511.731.84
PBDT9.7310.115.96
Depreciation2.682.632.62
Tax2.002.251.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.070.07-0.34
Reported Profit After Tax4.985.162.68
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item4.985.162.68
    
EPS (Unit Curr.)16.4617.068.85
EPS (Adj) (Unit Curr.)16.4617.068.85
Calculated EPS (Unit Curr.)16.4617.068.85
Calculated EPS (Adj) (Unit Curr.)16.4617.068.85
Calculated EPS (Ann.) (Unit Curr.)65.8668.2435.39
Calculated EPS (Adj) (Ann.) (Unit Curr.)65.8668.2435.39
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity3.023.023.02
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)14.4414.999.13
PBDTM(%)12.5012.796.98
PATM(%)6.406.533.14